Mutation Spectrum of Chinese Patients with Familial and Sporadic Amyotrophic Lateral Sclerosis
Qing Liu,Fang Liu,Bo Cui,Chao Lü,Xia Guo,Rong,Ming-Sheng Liu,Xiao Guang Li,Liying Cui,Xue Zhang
DOI: https://doi.org/10.1136/jnnp-2016-313337
2016-01-01
Abstract:Amyotrophic lateral sclerosis (ALS) is a fatal neurological disorder characterised by motor neuron degeneration in the primary motor cortex, brainstem and spinal cord. In two studies, >20 genes were associated with ALS and a number of patients carried potentially pathogenic variants in multiple ALS genes.1 ,2 We investigated the burden of influence of variants on ALS phenotype, and genetic profile of familial ALS (FALS) and sporadic ALS (SALS) in Chinese patients. From 2009 to 2014, 254 Chinese patients diagnosed as having probable or definite ALS according to El Escorial criteria,3 at our clinic centre, were enrolled for genetic study. FALS was defined as patients having a first-degree relative with ALS. Multiple neurodegenerative genes including 24 known ALS genes ( SOD1 , ALS2 , SETX , FUS , VAPB , ANG , TARDBP , FIG4 , OPTN , VCP , UBQLN2 , SIGMAR1 , CHMP2B , PFN1 , C9ORF72 , ATXN2 , AR , DCTN1 , NEFH , PRPH , DAO , TFG , TAF15 and GRN ) were incorporated into one screening panel, for sequence analysis. Detailed methods for targeting next-generation sequencing can be seen in online supplementary materials. In short, genomic DNA was extracted from peripheral blood leucocytes, and selective Ion Sphere Particles (ISPs) with qualified DNA were sequenced on Ion 318 Chips (8 samples/chip) by Ion Personal Genome Machine (PGM) Sequencer. At least 300 000 reads with a quality score of were obtained per sample, with a coverage of ∼96.5% for targeted regions …